Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109706947 | 10970694 | 7 | F | 2014 | 20160826 | 20150331 | 20160826 | EXP | US-PFIZER INC-2015104192 | PFIZER | 58.00 | YR | M | Y | 63.00000 | KG | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109706947 | 10970694 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG, 1X/DAY | Y | V1N73729 | 21110 | 1 | MG | TABLET | QD | ||||
| 109706947 | 10970694 | 2 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 1 MG, 1X/DAY (WITH MEAL ) | Y | 21110 | 1 | MG | TABLET | QD | |||||
| 109706947 | 10970694 | 3 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | 3 MG, 1X/DAY (1MG TABLET, 3 TABLETS BY MOUTH EVERY MORNING) | Y | 21110 | 3 | MG | TABLET | QD | |||||
| 109706947 | 10970694 | 4 | SS | TACROLIMUS. | TACROLIMUS | 1 | 1 MG, DAILY (1MG, CAPSULES, 9 OR 10 DAILY) | Y | 0 | 1 | MG | ||||||||
| 109706947 | 10970694 | 5 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | 36000 IU, 4X/DAY (2 WITH EVERY MEAL SO 8 CAPSULES A DAY) | 0 | 36000 | IU | CAPSULE | QID | |||||||
| 109706947 | 10970694 | 6 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | 36000 IU, 2 WITH EACH MEAL | 0 | 36000 | IU | CAPSULE | ||||||||
| 109706947 | 10970694 | 7 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Oral | 1 MG, 3X/DAY TWO IN MORNING AND ONE AT NIGHT | 0 | 1 | MG | TID | |||||||
| 109706947 | 10970694 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 109706947 | 10970694 | 9 | C | MYRBETRIQ | MIRABEGRON | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | TABLET | QD | |||||||
| 109706947 | 10970694 | 10 | C | ASPIRIN. | ASPIRIN | 1 | 1 DF, UNK | 0 | 1 | DF | TABLET | ||||||||
| 109706947 | 10970694 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 40 MG, 2X/DAY | 0 | 40 | MG | TABLET | BID | |||||||
| 109706947 | 10970694 | 12 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0.04 MG, UNK | 0 | .04 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109706947 | 10970694 | 1 | Pancreatic disorder |
| 109706947 | 10970694 | 4 | Pancreatic disorder |
| 109706947 | 10970694 | 5 | Pancreatic disorder |
| 109706947 | 10970694 | 6 | Diarrhoea |
| 109706947 | 10970694 | 8 | Renal disorder |
| 109706947 | 10970694 | 10 | Atrioventricular block |
| 109706947 | 10970694 | 11 | Renal disorder |
| 109706947 | 10970694 | 12 | Prostatomegaly |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109706947 | 10970694 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109706947 | 10970694 | Abdominal pain upper | |
| 109706947 | 10970694 | Amnesia | |
| 109706947 | 10970694 | Diarrhoea | |
| 109706947 | 10970694 | Eating disorder | |
| 109706947 | 10970694 | Fatigue | |
| 109706947 | 10970694 | Loss of consciousness | |
| 109706947 | 10970694 | Malaise | |
| 109706947 | 10970694 | Overdose | |
| 109706947 | 10970694 | Product use issue | |
| 109706947 | 10970694 | Renal impairment | |
| 109706947 | 10970694 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109706947 | 10970694 | 1 | 2004 | 0 | ||
| 109706947 | 10970694 | 2 | 19750904 | 0 | ||
| 109706947 | 10970694 | 3 | 2004 | 0 | ||
| 109706947 | 10970694 | 4 | 2004 | 0 |